Cannula Market Research, 2033
The global cannula market size was valued at $171.9 million in 2023, and is projected to reach $316.9 million by 2033, growing at a CAGR of 6.7% from 2024 to 2033.
Market Definition and Overview
A cannula is a medical device that consists of a thin tube inserted into the body for the delivery or removal of fluids, medications, or gases. Cannulas are commonly used in various medical procedures, including intravenous (IV) therapy, anesthesia administration, blood transfusions, and drainage of fluids from the body. The design of a cannula can vary depending on its intended use. Some cannulas have a sharp, pointed tip for piercing through tissues, while others have a blunt tip for safer insertion into delicate areas. They are typically made of materials such as plastic, metal, or silicone.
Cannulas are used in both clinical settings, such as hospitals and healthcare facilities, and in home healthcare settings. They play a crucial role in providing patients with necessary medications, fluids, or treatments, as well as assisting in diagnostic and therapeutic procedures.
Key Takeaways
- The cannula market forecast study covers 20 countries. The research includes a segment analysis of each country in terms of value ($million) for the projected period from 2024 to 2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major cannula industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The rise in surgical procedures, including minimally invasive surgeries, cosmetic surgeries, and cardiovascular procedures, is driving the demand for cannulas. Cannulas are essential instruments in various surgical interventions. The increasing demand for aesthetic procedures such as liposuction, facial rejuvenation, and breast augmentation is fueling the growth of the cannula market. Cannulas are preferred over needles in many aesthetic procedures due to reduced tissue trauma and more precise delivery of substances. Chronic diseases such as diabetes, cardiovascular diseases, and respiratory disorders require regular administration of medications or monitoring of physiological parameters. Cannulas are commonly used in these applications, contributing to cannula market growth.
The cost of cannula devices, especially those equipped with advanced features or made from specialized materials, can be significant. This high cost may deter healthcare facilities from investing in newer technologies or from replacing existing devices, particularly in regions with budget constraints or limited healthcare resources. All these factors are anticipated to restraint the cannula market share
Advances in material science and manufacturing technologies have led to the development of more advanced and specialized cannulas. These innovations improve patient outcomes, reduce procedure times, and enhance overall surgical efficiency, thereby driving market growth. Stringent regulatory standards ensure the quality, safety, and efficacy of medical devices, including cannulas. Compliance with these regulations is crucial for market players to gain and maintain market access, which also acts as a factor shaping the market dynamics. These factors are anticipated to drive the cannula market size opportunities.
Patent Analysis of Global Cannula Market
The patent titled "A Nasal Cannula, Conduit and Securement System" was published on May 9, 2024, by the Australian patent office. The applicants, Fisher & Paykel Healthcare Limited, describe a medical breathing tube comprising a tubular body with a lumen extending between its open terminal ends. The lumen contains an internal form, which is coated and secured to the tubular body. This internal form may also feature corrugations for additional support. The system includes patient interfaces, such as masks or nasal cannulae, and a securement mechanism for maintaining the operational position of these interfaces.
Market Segmentation
The cannula market is segmented into product, application, end user, and region. On the basis of product, the market is divided into nasal cannula, vascular cannula, venous cannula, cardiac cannula, arthroscopy cannula, intravenous cannula, dermatology cannula, and others. As per application, the market is segregated into orthopedics surgery, general surgery, cardiovascular surgery, plastic surgery, oxygen therapy, and others. On the basis of end user, the market is segmented into hospitals, clinics, ambulatory surgery centers, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Regional Market Outlook
North America plays a vital role in driving the global cannula market due to several factors, including an increase in surgical procedures and minimally invasive interventions, escalating incidents of injuries, a rise in bariatric surgeries, and heightened hospital admissions across the region. For instance, as per the US Bureau of Labor Statistics data from 2021, there were 2, 607, 900 non-fatal injuries reported in private industries in the U.S. This uptrend suggests a higher likelihood of injuries requiring surgical intervention, amplifying the demand for cannulas.
Ongoing advancements in cannula designs, materials, and manufacturing techniques lead to the development of more efficient and patient-friendly products. These innovations attract healthcare providers and patients alike, driving cannula market share growth.
Competitive Landscape
The major players operating in the cannula industry include Medtronic, Becton Dickinson (BD) , Edward Lifesciences, LivaNova, Smiths Medical, Boston Scientific Corporation, Terumo Corporation, Fisher & Paykel Healthcare Ltd, Flexicare Medical, and Medin Medical Innovations.
Recent Key Strategies and Developments
- In February 2022, Gilde Healthcare, a venture capital firm focusing on healthcare technologies, completed the acquisition of EUROPIN, a prominent manufacturer of medical needles. This acquisition aims to create a contract manufacturer for custom-made cannulas and cannula systems, enhancing their market position and capabilities in the healthcare sector. .
- In September 2021, PDO Max introduced a new product designed for virtually painless PDO Thread Procedures. The Cannula Max features a 21G x 100mm blunt numbing cannula, providing a convenient method for numbing the insertion path of polydioxanone (PDO) threads.
Industry Trends
- The ISAPS report, released in January 2022, highlighted that the top five cosmetic surgeries performed globally in 2020 were breast augmentation (1, 624, 281 procedures) , liposuction (1, 525, 197 procedures) , eyelid surgery (1, 225, 540 procedures) , rhinoplasty (852, 554 procedures) , and abdominoplasty (765, 248 procedures) . Given the high volume of aesthetic surgeries, the use of cannulas in these procedures is expected to increase in popularity, driven by the growing demand within the field of aesthetics.
- An article published in ScienceDirect in October 2022 detailed a study on the use of the Berlin Heart EXCOR Venous Cannula for implantation and support in pediatric patients with terminal heart failure. Research studies and case presentations like this are expected to drive the demand for medical cannulas, contributing to market growth. The increasing focus on advanced medical interventions and supportive technologies underscores the expanding role of cannulas in various medical procedures.
Key Sources Referred
- Company Annual Reports
- Investor Presentations
- Press Releases
- Research Papers
- D&B Hoovers
- ZoomInfo Technologies LLC
- Health central coast local Health District
- WHO
- American Society of Anesthesiologists (ASA)
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cannula market analysis from 2024 to 2033 to identify the prevailing cannula market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cannula market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cannula market trends, key players, market segments, application areas, and market growth strategies.
Cannula Market Report Highlights
Aspects | Details |
Market Size By 2033 | USD 316.9 Million |
Growth Rate | CAGR of 6.7% |
Forecast period | 2024 - 2033 |
Report Pages | 320 |
By Product |
|
By Application |
|
By End User |
|
By Region |
|
Key Market Players | Flexicare Medical, Medtronic, Becton Dickinson (BD), Medin Medical Innovations, Edward Lifesciences, LivaNova, Terumo Corporation, Boston Scientific Corporation, Fisher & Paykel Healthcare Ltd, Smiths Medical |
The cannula market is trending towards increased use in minimally invasive procedures, advancements in materials for improved biocompatibility, and rising demand in cosmetic and medical applications globally.
The cannula market was valued at $171.87 million in 2023 and is estimated to reach $316.88 million by 2033, exhibiting a CAGR of 6.7% from 2024 to 2032.
The leading application of the Cannula Market is in cosmetic surgery, particularly for dermal fillers and injectables, due to precise delivery and reduced trauma to tissues.
The top companies leading the cannula market include Boston Scientific Corporation, Medtronic plc, Teleflex Incorporated, Conmed Corporation, and Smiths Group plc, known for their innovative medical devices and solutions.
The largest regional market for cannulas is North America, driven by advanced healthcare infrastructure, high healthcare expenditure, and a significant prevalence of chronic diseases requiring surgical interventions.
Loading Table Of Content...